Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of P-Cymene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.40 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| P-Cymene SCHEMBL29369703 | 1.00 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL30358042 | 0.94 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL30844107 | 0.94 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL3996547 | 0.94 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL7865320 | 0.94 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL23388162 | 0.94 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL5179600 | 0.94 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL3697148 | 0.94 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL23388160 | 0.94 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL1697748 | 0.94 | ACHE (0.53) | ACHETDP1CHRNA7BCHETYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115650824-B | Chiral diol and preparation method thereof, prepared catalyst and preparation method and application thereof | 合肥工业大学 | 2024-01-23 | — | — | CN | claimed |
| EP-2382172-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE COMPOUNDS USING TRANSFER HYDROGENATION | Novartis AG (CH) | 2011-11-02 | — | — | EP | claimed |
| WO-2010072798-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE COMPOUNDS USING TRANSFER HYDROGENATION | NOVARTIS AG (CH) | 2010-07-01 | — | — | WO | claimed |
| CN-115650824-B | Chiral diol and preparation method thereof, prepared catalyst and preparation method and application thereof | 合肥工业大学 | 2024-01-23 | — | — | CN | disclosed |
| CN-116789636-A | Bifunctional compound, preparation method, pharmaceutical composition and application thereof | 北京康辰药业股份有限公司 | 2023-09-22 | — | — | CN | disclosed |